The drug produced an oculocutaneomucous syndrome with severe eye involvement, and was recalled

Last update : 15/10/2015
I - Interstitial/parenchymal lung disease
IV - Airway involvement
V - Pleural and/or pericardial involvement
X - Systemic/Distant conditions, syndromes and reactions
XII - Cardiovascular involvement / toxicity